Singular Genomics

Singular Genomics is a company listed under the stock ticker OMIC (US).

View the org chart displaying its 15 main executives

Most searched biographies at Singular Genomics

• Andrew Spaventa, Chief Executive Officer and Chairman of the Board
• Elaine Mardis, Director
• Mike Pellini, Board Member

Popular executive movements at Singular Genomics

• Marcia Eisenberg has joined the company as Director  (posted on August 9 2023).

Create your alert
to follow the executive moves at Singular Genomics.

Singular Genomics has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Singular Genomics

Social media about Singular Genomics

• Singular Genomics on Wikipedia, Google News & Yahoo Finance
• Singular Genomics on LinkedIn, Twitter & YouTube

Contact by email its executives including Andrew Spaventa

Call Singular Genomics at +1 858...

View the org chart

Register to receive your alert

Report an error